Type I interferon dysregulation in Systemic Sclerosis
- 23 January 2019
- journal article
- research article
- Published by Elsevier BV in Cytokine
- Vol. 132, 154635
- https://doi.org/10.1016/j.cyto.2018.12.018
Abstract
No abstract availableKeywords
Funding Information
- Bayer HealthCare
This publication has 85 references indexed in Scilit:
- Systemic sclerosisThe Lancet, 2017
- Unfolding the pathogenesis of scleroderma through genomics and epigenomicsJournal of Autoimmunity, 2017
- Haematopoietic stem cell transplantation for autoimmune diseasesNature Reviews Rheumatology, 2017
- Importance of Nucleic Acid Recognition in Inflammation and AutoimmunityAnnual Review of Medicine, 2016
- Systemic sclerosisNature Reviews Disease Primers, 2015
- Type I interferons in infectious diseaseNature Reviews Immunology, 2015
- Regulation of type I interferon responsesNature Reviews Immunology, 2013
- What does global gene expression profiling tell us about the pathogenesis of systemic sclerosis?Current Opinion in Rheumatology, 2013
- The IRF Family Transcription Factors in Immunity and OncogenesisAnnual Review of Immunology, 2008
- Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohortsArthritis & Rheumatism, 2001